Qiang Fu

2.9k total citations
118 papers, 2.2k citations indexed

About

Qiang Fu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Qiang Fu has authored 118 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 42 papers in Pulmonary and Respiratory Medicine and 30 papers in Oncology. Recurrent topics in Qiang Fu's work include Renal cell carcinoma treatment (24 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Sexual function and dysfunction studies (14 papers). Qiang Fu is often cited by papers focused on Renal cell carcinoma treatment (24 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Sexual function and dysfunction studies (14 papers). Qiang Fu collaborates with scholars based in China, United States and Malaysia. Qiang Fu's co-authors include Jiejie Xu, Le Xu, Weijuan Zhang, Hangcheng Fu, Yu Zhu, Zhanguo Yue, Wei Wei, Hua Yue, Guanghui Ma and Piping Lv and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Qiang Fu

117 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiang Fu China 23 1.0k 494 452 439 408 118 2.2k
Ting Wu China 18 1.0k 1.0× 766 1.6× 478 1.1× 548 1.2× 456 1.1× 60 2.2k
Cian M. McCrudden United Kingdom 32 1.4k 1.4× 506 1.0× 209 0.5× 515 1.2× 235 0.6× 52 3.1k
Curtis B. Thompson United States 24 1.3k 1.2× 1.1k 2.3× 234 0.5× 430 1.0× 372 0.9× 51 2.6k
Qian Xiao China 27 1.3k 1.2× 952 1.9× 233 0.5× 509 1.2× 609 1.5× 111 2.7k
Maria Teresa Scupoli Italy 31 1.2k 1.2× 692 1.4× 192 0.4× 770 1.8× 421 1.0× 75 3.0k
Magdalena Król Poland 23 790 0.8× 467 0.9× 453 1.0× 272 0.6× 274 0.7× 81 1.8k
Xiao Zhao China 21 1.3k 1.2× 471 1.0× 261 0.6× 413 0.9× 587 1.4× 53 2.7k
Juliane Winkler Germany 15 1.8k 1.7× 668 1.4× 190 0.4× 369 0.8× 428 1.0× 20 2.9k
Oliver M.T. Pearce United Kingdom 23 1.3k 1.2× 623 1.3× 188 0.4× 923 2.1× 218 0.5× 43 2.5k
Thomas A. Haas Canada 22 1.4k 1.3× 272 0.6× 187 0.4× 492 1.1× 315 0.8× 43 3.2k

Countries citing papers authored by Qiang Fu

Since Specialization
Citations

This map shows the geographic impact of Qiang Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Fu more than expected).

Fields of papers citing papers by Qiang Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiang Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Fu. The network helps show where Qiang Fu may publish in the future.

Co-authorship network of co-authors of Qiang Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiang Fu. A scholar is included among the top collaborators of Qiang Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiang Fu. Qiang Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yandong, Haodong Li, Juntang Lin, et al.. (2025). Engineering nanozyme immunomodulator with magnetic targeting effect for cascade-enzyodynamic and ultrasound-reinforced metallo-immunotherapy in prostate carcinoma. Nature Communications. 16(1). 1876–1876. 18 indexed citations
2.
3.
Gao, Fucheng, Qiang Fu, Ying Ruan, et al.. (2025). Elucidating Manganese Single‐Atom Doping: Strategies for Fluorescence Enhancement in Water‐Soluble Red‐Emitting Carbon Dots and Applications for FL/MR Dual Mode Imaging. Advanced Science. 12(8). e2414895–e2414895. 9 indexed citations
4.
Wang, Yandong, Haodong Li, Fei Chang, et al.. (2025). Dynamic Redox‐Switchable Nanotransducer Enabling Spatiotemporal cGAS‐STING Remodeling and Immunogenic Cell Death Induction for Cancer Immunotherapy. Advanced Functional Materials. 35(52). 1 indexed citations
5.
Guo, Zhongkai, et al.. (2024). Saffron extract alleviates D-gal-induced late-onset hypogonadism by activating the PI3K-Akt-Nrf2 signaling pathway. Journal of Ethnopharmacology. 340. 119273–119273. 1 indexed citations
6.
Fu, Qiang, Keqin Zhang, Wenfu Wang, et al.. (2023). Nomograms Combining PHI and PI-RADS in Detecting Prostate Cancer: A Multicenter Prospective Study. Journal of Clinical Medicine. 12(1). 339–339. 8 indexed citations
8.
Zhao, Danfeng, et al.. (2023). Effects of endoplasmic reticulum stress on erectile function in rats with cavernous nerve injury. Sexual Medicine. 11(4). qfad050–qfad050. 3 indexed citations
9.
Xu, Yaolin, et al.. (2021). Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints. Frontiers in Oncology. 11. 759015–759015. 28 indexed citations
10.
Fu, Hangcheng, Yu Zhu, Yiwei Wang, et al.. (2018). Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer. Clinical Cancer Research. 24(13). 3069–3078. 127 indexed citations
11.
Zhang, Junyu, Yu Zhu, Yiwei Wang, et al.. (2017). Prognostic and Predictive Value of O6-methylguanine Methyltransferase for Chemotherapy in Patients with Muscle-Invasive Bladder Cancer. Annals of Surgical Oncology. 25(1). 342–348. 4 indexed citations
12.
Liu, Weisi, Yidong Liu, Haiou Liu, et al.. (2015). Tumor Suppressive Function of p21-activated Kinase 6 in Hepatocellular Carcinoma. Journal of Biological Chemistry. 290(47). 28489–28501. 20 indexed citations
13.
Wang, Yawen, Duan‐Bo Shi, Yamin Liu, et al.. (2014). Aberrant expression of CD227 is correlated with tumor characteristics and invasiveness of breast carcinoma. Journal of Cancer Research and Clinical Oncology. 140(8). 1271–1281. 4 indexed citations
14.
Ma, Hui, et al.. (2012). Identification of ankylosing spondylitis-associated genes by expression profiling. International Journal of Molecular Medicine. 30(3). 693–696. 5 indexed citations
15.
Fu, Qiang. (2008). Relationship between expression of STAT3 phosphorylation and lymph node metastasis in breast cancer. Zhonghua zhongliu fangzhi zazhi. 1 indexed citations
16.
Liu, Zheng, et al.. (2008). Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. Journal of Experimental & Clinical Cancer Research. 27(1). 51–51. 32 indexed citations
17.
Fu, Qiang, et al.. (2001). Effect of sodium nitroprusside on hemodynamics of corpus cavernosum in Chinese.. PubMed. 3(4). 311–3. 6 indexed citations
18.
Zhang, Jianxuan, Long Yu, Qiang Fu, et al.. (2001). Mouse phosphoglycerate mutase M and B isozymes: cDNA cloning, enzyme activity assay and mapping. Gene. 264(2). 273–279. 24 indexed citations
19.
Fu, Qiang, Long Yu, Qing Liu, et al.. (2000). Molecular Cloning, Expression Characterization, and Mapping of a Novel Putative Inhibitor of Rho GTPase Activity, RTKN, to D2S145–D2S286. Genomics. 66(3). 328–332. 19 indexed citations
20.
Zhang, Pingzhao, Long Yu, Jie Gao, et al.. (2000). Cloning and Characterization of Human VPS35 and Mouse Vps35 and Mapping of VPS35 to Human Chromosome 16q13–q21. Genomics. 70(2). 253–257. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026